Unexpectedly, CXCR2 ligands such as CXCL1-3 and 8 were decreased in the progression of CXCR2-driven ovarian cancer compared to relatively constant CCL20 levels (Fig 5). Here, CXCR2 is linked to ovarian carcinoma.